Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression

Genetic Vaccines and Therapy

Volumn 7, Issue , 2009, Pages

  Trinh, Alice T ^a   Ball, Bret G ^b   Weber, Erin ^c   Gallaher, Timothy K ^a   Gluzman Poltorak, Zoya ^a   Anderson, French ^a   Basile, Lena A ^a  

^a Neumedicines Inc   (United States)

^b MAYO CLINIC   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ENHANCED GREEN FLUORESCENT PROTEIN; PHOSPHOGLYCERATE KINASE; RETROVIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; INTRON; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; POLYADENYLATION; PROMOTER REGION; REPORTER GENE; SEVERE COMBINED IMMUNODEFICIENCY; T LYMPHOCYTE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

MAMMALIA; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE;

EID: 74549206662     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-7-13     Document Type: Article

References (45)

1. Silver JN, Flotte TR. Towards a rAAV-based gene therapy for ADA-SCID: from ADA deficiency to current and future treatment strategies. Pharmacogenomics 2008, 9:947-68. 10.2217/14622416.9.7.947, 18597656.
2. Hershfield MS, Chaffee S, Sorensen RU. Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy. Pediatric Research 1993, 33:S42-7. 10.1203/00006450-199304001-00009, 8433874.
3. Hershfield MS. PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency. Human Mutation 1995, 5:107-12. 10.1002/humu.1380050202, 7749407.
4. Woodard P, Lubin B, Walters CM. New approaches to hematopoietic cell transplantation for hematological diseases in children. Pediatr Clin North Am 2002, 49:989-1007. 10.1016/S0031-3955(02)00026-3, 12430622.
5. Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, Scaramuzza S, Andolfi G, Mirolo M, Brigida I, Tabucchi A, Carlucci F, Eibl M, Aker M, Slavin S, Al-Mousa H, Ghonaium AA, Ferster A, Duppenthaler A, Notarangelo L, Wintergerst U, Buckley RH, Bregni M, Marktel S, Valsecchi MG, Rossi P, Ciceri F, Miniero R, Bordignon C, Roncarolo MG. Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency. N Engl J Med 2009, 360:447-58. 10.1056/NEJMoa0805817, 19179314.
6. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavilio F. Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA Immunodeficient Patients. Science 1995, 270:470-475. 10.1126/science.270.5235.470, 7570000.
7. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 1995, 270:475-80. 10.1126/science.270.5235.475, 7570001.
8. Swindle CS, Klug CA. Mechanisms that regulate silencing of gene expression from retroviral vectors. J Hematother Stem Cell Res 2002, 11:449-56. 10.1089/15258160260090915, 12183830.
9. Rivella S, Callegari JA, May C, Tan CW, Sadelain M. The cHS4 Insulator Increases the Probability of Retroviral Expression at Random Chromosomal Integration Sites. J Virol 2000, 74:4679-87. 10.1128/JVI.74.10.4679-4687.2000, 111989, 10775605.
10. Klug CA, Cheshier S, Weissman IL. Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny. Blood 2000, 96:894-901.
11. McCormack MP, Rabbits TH. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2004, 350:913-922. 10.1056/NEJMra032207, 14985489.
12. Nienhuis AW. Development of gene therapy for blood disorders. Blood 2008, 111:4431-4444. 10.1182/blood-2007-11-078121, 18441245.
13. Bushman FD. Retroviral integration and human gene therapy. J Clin Invest 2007, 117:2083-6. 10.1172/JCI32949, 1934602, 17671645.
14. Schneider R, Grosschedl R. Dynamics and interplay of nuclear architecture, genome organization, and gene expression. Genes Dev 2007, 21:3027-43. 10.1101/gad.1604607, 18056419.
15. Gilbert N, Boyle S, Fiegler H, Woodfine K, Carter NP, Bickmore WA. Chromatin architecture of the human genome: gene-rich domains are enriched in open chromatin fibers. Cell 2004, 118:555-66. 10.1016/j.cell.2004.08.011, 15339661.
16. Crusselle-Davis VJ, Vieira KF, Zhou Z, Anantharaman A, Bungert J. Antagonistic Regulation of β-Globin Gene Expression by Helix-Loop-Helix Proteins USF and TFII-I. Mol Cell Biol 2006, 26:6832-43. 10.1128/MCB.01770-05, 1592872, 16943425.
17. Baum C, Dullman J, Li Z, Fesha B, Meyer J, Williams DA, Von Kalle C. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003, 101:2099-2114. 10.1182/blood-2002-07-2314, 12511419.
18. Hanawa H, Hargrove PW, Kepes S, Srivastava DK, Nienhuis AW, Persons DA. Extended β-globin locus control region elements promote consistent therapeutic expression of a γ-globin lentiviral vector in murine β-thalassemia. Blood 2004, 104:2281-2290. 10.1182/blood-2004-03-0863, 15198957.
19. Imren S, Fabry ME, Westerman KA, Pawliuk R, Tang P, Rosten PM, Nagel RL, Leboulch P, Eaves CJ, Humphries RK. High level β-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells. J Clin Invest 2004, 114:953-962. 518665, 15467834.
20. Levasseur DN, Ryan TM, Pawlik KM, Townes TM. Correction of a mouse model of sickle cell disease: lentiviral/antisickling β-globin gene transduction of unmobilized, purified hematopoietic stem cells. Blood 2003, 102:4312-4319. 10.1182/blood-2003-04-1251, 12933581.
21. Ramezani A, Hawley TS, Hawley RG. Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator. Blood 2003, 101:4717-4724. 10.1182/blood-2002-09-2991, 12586614.
22. Rivella S, May C, Chadburn A, Riviere I, Sadelain M. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human β-globin gene transfer. Blood 2003, 101:2932-2939. 10.1182/blood-2002-10-3305, 12480689.
23. Woods NB, Muessig A, Sscmidt M, Flygare J, Olsson K, Salmon P, Tronto D, Von Kalle C, Karlsson S. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis. Blood 2003, 101:1284-1289. 10.1182/blood-2002-07-2238, 12393514.
24. Wiginton DA, Kaplan DJ, States JC, Akeson AL, Perme CM, Bilyk IJ, Vaughn AJ, Lattier DL, Hutton JJ. Complete sequence and structure of the gene for human adenosine deaminase. Biochemistry 1986, 25:8234-44. 10.1021/bi00373a017, 3028473.
25. Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM, Kingsman AJ. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucl Acids Res 1995, 23:628-633. 10.1093/nar/23.4.628, 306730, 7899083.
26. Kotani H, Newton PB, Zhang S, Chiang YL, Otto E, Weaver L, Blease RM, Anderson WF, McGarrity GJ. Improved methods of retroviral vector transduction and production for gene therapy. Human Gene Therapy 1994, 5:19-28. 10.1089/hum.1994.5.1-19, 8155767.
27. Aronow B, Lattier D, Silbiger R, Dusing M, Hutton J, Jones G, Stock J, MCNeish J, Potter S, Witte D, Wiginton D. Evidence for a complex regulatory array in the first intron of the human adenosine deaminase gene. Genes Dev 1989, 3(9):1384-1400. 2606352, 10.1101/gad.3.3.384.
28. Lin AH, Kasahara N, Wu W, Stripecke R, Empig CL, Anderson WF, Cannon PM. Receptor-Specific Targeting Mediated by the Coexpression of a Targeted Murine Leukemia Virus Envelope Protein and a Binding-Defective Influenza Hemagglutinin Protein. Hum Gene Ther 2001, 12:323-332. 10.1089/10430340150503957, 11242525.
29. Abada P, Noble B, Cannon PM. Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production. J Virol 2005, 79:3627-38. 10.1128/JVI.79.6.3627-3638.2005, 1075700, 15731257.
30. Zhu NL, Cannon PM, Chen D, Anderson WF. Mutational Analysis of the Fusion Peptide of Moloney Murine Leukemia Virus Transmembrane Protein p15E. J Virol 1998, 72:1632-1639. 124647, 9445069.
31. Han JY, Cannon P, Lai KM, Zhao Y, Eiden MV, Anderson WF. Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus. J Virol 1997, 71:8103-8108. 192265, 9343159.
32. Zhao Y, Lin Y, Zhan Y, Yang G, Louie J, Harrison BE, Anderson WF. Murine hematopoietic stem cell characterization and its regulation in bone marrow transplantation. Blood 2000, 96:3016-3022.
33. Hanawa H, Hematti P, Keyvanfar K, Metzger ME, Krouse A, Donahue RE, Kepes S, Gray J, Dunbar CE, Persons DA, Nienhuis AW. Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 2004, 103:4062-4069. 10.1182/blood-2004-01-0045, 14976042.
34. Yu SF, Von Ruden T, Kantoff P, Garber C, Seiberg M, Ruther U, Anderson WF, Wagner EF, Gilboa E. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci USA 1986, 83:3194-3198. 10.1073/pnas.83.10.3194, 323479, 3458176.
35. Blackwood EM, Kadonaga JT. Going the distance: a current view of enhancer action. Science 1998, 281(5373):60-63. 9679020, 10.1126/science.281.5373.60.
36. Tanimoto K, Liu Q, Bungert J, Engel JD. Effects of altered gene order or orientation of the locus control region on human beta-globin gene expression in mice. Nature 1999, 398:344-348. 10.1038/18698, 10192336.
37. Barklis E, Mulligan RC, Jaenisch R. Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell 1986, 47:391-399. 10.1016/0092-8674(86)90596-9, 3768959.
38. Ismail SI, Kingsman SM, Kingsman AJ, Uden M. Split-intron retroviral vectors: enhanced expression with improved safety. J Virol 2000, 74:2365-71. 10.1128/JVI.74.5.2365-2371.2000, 111718, 10666267.
39. Strauss JH, Strauss EG. Gene Therapy: Virus Vector Systems. Viruses and Human Disease 2002, 347-356. San Diego: Academic Press, 1.
40. Ellis J, Pannell D. The beta-globin locus control region versus gene therapy vectors: a struggle for expression. Clin Genet 2001, 59(1):17-24. 11168020, 10.1034/j.1399-0004.2001.590103.x.
41. Emery DW, Yannaki E, Tubb J, Nishino T, Li Q, Stamatoyannopoulos G. Development of virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo . Blood 2002, 100:2012-2019. 10.1182/blood-2002-01-0219, 12200360.
42. Oh IH, Fabry ME, Humphries RK, Pawliuk R, LeBoulch P, Hoffman RL, Eaves C. Expression of an anti-sickling β-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells. Exp Hematol 2004, 32(5):461-469. 15145214, 10.1016/j.exphem.2004.02.001.
43. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, El-Khoureiy A, Kim L, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Craig A, Mullen R, Blease M, Parkman R. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med 1995, 1:1017-1023. 10.1038/nm1095-1017, 7489356.
44. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000, 288:669-672. 10.1126/science.288.5466.669, 10784449.
45. Schwarzwaelder K, Howe SJ, Schmidt M, Brugman MH, Deichmann A, Glimm H, Schmidt S, Prinz C, Wissler M, King DJ, Zhang F, Parsley KL, Gilmour KC, Sinclair J, Bayford J, Peraj R, Pike-Overzet K, Staal FJ, de Ridder D, Kinnon C, Abel U, Wagemaker G, Gaspar HB, Thrasher AJ, von Kalle C. Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J Clin Invest 2007, 117:2241-9. 10.1172/JCI31661, 1934556, 17671654.